{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["amygdala", "arginine vasopressin", "autism spectrum disorder", "neurodevelopmental", "oligodendrocyte"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": [], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35401102", "DateRevised": {"Year": "2022", "Month": "04", "Day": "13"}, "Article": {"ArticleDate": [{"Year": "2022", "Month": "03", "Day": "25"}], "Language": ["eng"], "ELocationID": ["838942", "10.3389/fnins.2022.838942"], "Journal": {"ISSN": "1662-4548", "JournalIssue": {"Volume": "16", "PubDate": {"Year": "2022"}}, "Title": "Frontiers in neuroscience", "ISOAbbreviation": "Front Neurosci"}, "ArticleTitle": "The Changes of Amygdala Transcriptome in Autism Rat Model After Arginine Vasopressin Treatment.", "Pagination": {"StartPage": "838942", "MedlinePgn": "838942"}, "Abstract": {"AbstractText": ["Some studies have shown that arginine vasopressin (AVP) can significantly improve the social interaction disorder of autism, but the mechanism remains unclear.", "Female Wistar rats were intraperitoneally injected with VPA or normal saline at embryonic day 12.5 to establish an autism model or normal control in their offspring. Male offspring prenatally exposed to VPA were randomly assigned to two groups: the VPA-induced autism model group and the AVP group. The rats in the AVP group were treated with intranasal AVP at postnatal day (PND) 21 and for 3 weeks. The VPA-induced autism model group was given the same dose of normal saline in the same way. Behavioral responses were evaluated in the open field and three-chambered social test apparatus; the expression levels of AVP in serum were detected by enzyme-linked immunosorbent assay kit, and the gene expression levels on the amygdala were measured by RNA-seq at PND42.", "Intranasal administration of AVP can significantly improve the social interaction disorder and elevate the levels of AVP in serum. Transcriptome sequencing results showed that 518 differently expressed genes (DEGs) were identified in the VPA-induced autism model group compared with the control in this study. Gene Ontology biological process enrichment analysis of DEGs showed that the VPA-induced autism model group had significant nervous system developmental impairments compared with the normal group, particularly in gliogenesis, glial cell differentiation, and oligodendrocyte differentiation. Gene Set Enrichment Analysis (GSEA) enrichment analysis also showed that biological process of oligodendrocyte differentiation, axoneme assembly, and axon ensheathment were inhibited in the VPA-induced autism model group. Pathway enrichment analysis of DEGs between the control and VPA-induced autism model group showed that the PI3K/AKT and Wnt pathways were significantly dysregulated in the VPA-induced autism model group. Few DEGs were found when compared with the transcriptome between the VPA-induced autism model group and the AVP treatment group. GSEA enrichment analysis showed deficits in oligodendrocyte development and function were significantly improved after AVP treatment; the pathways were mainly enriched in the NOTCH, mitogen-activated protein kinase, and focal adhesion signaling pathways, but not in the PI3K/AKT and Wnt pathways. The expression patterns analysis also showed the same results.", "AVP can significantly improve the social interaction disorder of VPA-induced autism model, and AVP may target behavioral symptoms in autism by modulating the vasopressin pathways, rather than primary disease mechanisms."], "CopyrightInformation": "Copyright \u00a9 2022 Zhou, Zheng, Chen, Yan, Peng, Liu, Zhang, Tang and Wen."}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhou", "ForeName": "Bo", "Initials": "B"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Zheng", "ForeName": "Xiaoli", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "College of Basic Medical, Guizhou Medical University, Guiyang, China."}], "LastName": "Chen", "ForeName": "Yunhua", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Yan", "ForeName": "Xuehui", "Initials": "X"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Peng", "ForeName": "Jinggang", "Initials": "J"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Liu", "ForeName": "Yibu", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Zhang", "ForeName": "Yi", "Initials": "Y"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Tang", "ForeName": "Lei", "Initials": "L"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "State Key Laboratory of Functions and Applications of Medicinal Plants, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "Guizhou Provincial Engineering Technology Research Center for Chemical Drug R&D, Guizhou Medical University, Guiyang, China."}, {"Identifier": [], "Affiliation": "College of Pharmacy, Guizhou Medical University, Guiyang, China."}], "LastName": "Wen", "ForeName": "Min", "Initials": "M"}], "PublicationTypeList": ["Journal Article"]}, "MedlineJournalInfo": {"Country": "Switzerland", "MedlineTA": "Front Neurosci", "NlmUniqueID": "101478481", "ISSNLinking": "1662-453X"}, "CoiStatement": "The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Acar A., Hidalgo-Sastre A., Leverentz M. K., Mills C. G., Woodcock S., Baron M., et al. (2021). Inhibition of Wnt signalling by Notch via two distinct mechanisms. Sci. Rep. 11:9096. 10.1038/s41598-021-88618-5", "ArticleIdList": ["10.1038/s41598-021-88618-5", "PMC8079408", "33907274"]}, {"Citation": "Anders S., Pyl P. T., Huber W. (2015). HTSeq\u2013a Python framework to work with high-throughput sequencing data. Bioinformatics 31 166\u2013169. 10.1093/bioinformatics/btu638", "ArticleIdList": ["10.1093/bioinformatics/btu638", "PMC4287950", "25260700"]}, {"Citation": "Avino T. A., Barger N., Vargas M. V., Carlson E. L., Amaral D. G., Bauman M. D., et al. (2018). Neuron numbers increase in the human amygdala from birth to adulthood, but not in autism. Proc. Natl. Acad. Sci. U.S.A. 115 3710\u20133715. 10.1073/pnas.1801912115", "ArticleIdList": ["10.1073/pnas.1801912115", "PMC5889677", "29559529"]}, {"Citation": "Bai C., Zhang H., Zhang X., Yang W., Li X., Gao Y. (2019). MiR-15/16 mediate crosstalk between the MAPK and Wnt/beta-catenin pathways during hepatocyte differentiation from amniotic epithelial cells. Biochim. Biophys. Acta Gene Regul. Mech. 1862 567\u2013581. 10.1016/j.bbagrm.2019.02.003", "ArticleIdList": ["10.1016/j.bbagrm.2019.02.003", "30753902"]}, {"Citation": "Baron-Cohen S., Ring H. A., Bullmore E. T., Wheelwright S., Ashwin C., Williams S. C. (2000). The amygdala theory of autism. Neurosci. Biobehav. Rev. 24 355\u2013364. 10.1016/s0149-7634(00)00011-7", "ArticleIdList": ["10.1016/s0149-7634(00)00011-7", "10781695"]}, {"Citation": "Benarroch E. E. (2013). Oxytocin and vasopressin: social neuropeptides with complex neuromodulatory functions. Neurology 80 1521\u20131528. 10.1212/WNL.0b013e31828cfb15", "ArticleIdList": ["10.1212/WNL.0b013e31828cfb15", "23589638"]}, {"Citation": "Borie A. M., Dromard Y., Guillon G., Olma A., Manning M., Muscatelli F., et al. (2021). Correction of vasopressin deficit in the lateral septum ameliorates social deficits of mouse autism model. J. Clin. Invest. 131:e144450. 10.1172/JCI144450", "ArticleIdList": ["10.1172/JCI144450", "PMC7810497", "33232306"]}, {"Citation": "Bronzuoli M. R., Facchinetti R., Ingrassia D., Sarvadio M., Schiavi S., Steardo L., et al. (2018). Neuroglia in the autistic brain: evidence from a preclinical model. Mol. Autism 9:66. 10.1186/s13229-018-0254-0", "ArticleIdList": ["10.1186/s13229-018-0254-0", "PMC6307226", "30603062"]}, {"Citation": "Cartocci V., Catallo M., Tempestilli M., Segatto M., Pfrieger F. W., Bronzuoli M. R., et al. (2018). Altered brain cholesterol/isoprenoid metabolism in a rat model of autism spectrum disorders. Neuroscience 372 27\u201337. 10.1016/j.neuroscience.2017.12.053", "ArticleIdList": ["10.1016/j.neuroscience.2017.12.053", "29309878"]}, {"Citation": "Cherchi F., Pugliese A. M., Coppi E. (2021). Oligodendrocyte precursor cell maturation: role of adenosine receptors. Neural Regen. Res. 16 1686\u20131692. 10.4103/1673-5374.306058", "ArticleIdList": ["10.4103/1673-5374.306058", "PMC8328763", "33510056"]}, {"Citation": "Christensen D. L., Baio J., Van Naarden Braun K., Bilder D., Charles J., Constantino J. N., et al. (2016). Prevalence and characteristics of autism spectrum disorder among children aged 8 years\u2013autism and developmental disabilities monitoring network, 11 Sites, United States, 2012. MMWR Surveill. Summ. 65 1\u201323. 10.15585/mmwr.ss6802a1", "ArticleIdList": ["10.15585/mmwr.ss6802a1", "PMC7909709", "27031587"]}, {"Citation": "Dai Y. C., Zhang H. F., Schon M., Bockers T. M., Han S. P., Han J. S., et al. (2018). Neonatal oxytocin treatment ameliorates autistic-like behaviors and oxytocin deficiency in valproic acid-induced rat model of autism. Front. Cell Neurosci. 12:355. 10.3389/fncel.2018.00355", "ArticleIdList": ["10.3389/fncel.2018.00355", "PMC6190900", "30356897"]}, {"Citation": "Duncan G. J., Simkins T. J., Emery B. (2021). Neuron-oligodendrocyte interactions in the structure and integrity of axons. Front. Cell Dev. Biol. 9:653101. 10.3389/fcell.2021.653101", "ArticleIdList": ["10.3389/fcell.2021.653101", "PMC7982542", "33763430"]}, {"Citation": "Emery B. (2010). Regulation of oligodendrocyte differentiation and myelination. Science 330 779\u2013782. 10.1126/science.1190927", "ArticleIdList": ["10.1126/science.1190927", "21051629"]}, {"Citation": "Ferrara N. C., Trask S., Avonts B., Loh M. K., Padival M., Rosenkranz J. A. (2021). Developmental shifts in amygdala activity during a high social drive state. J. Neurosci. 41 9308\u20139325. 10.1523/JNEUROSCI.1414-21.2021", "ArticleIdList": ["10.1523/JNEUROSCI.1414-21.2021", "PMC8580147", "34611026"]}, {"Citation": "Forrest A. D., Beggs H. E., Reichardt L. F., Dupree J. L., Colello R. J., Fuss B. (2009). Focal adhesion kinase (FAK): a regulator of CNS myelination. J. Neurosci. Res. 87 3456\u20133464. 10.1002/jnr.22022", "ArticleIdList": ["10.1002/jnr.22022", "PMC2760606", "19224576"]}, {"Citation": "Graciarena M., Seiffe A., Nait-Oumesmar B., Depino A. M. (2018). Hypomyelination and oligodendroglial alterations in a mouse model of autism spectrum disorder. Front. Cell Neurosci. 12:517. 10.3389/fncel.2018.00517", "ArticleIdList": ["10.3389/fncel.2018.00517", "PMC6338056", "30687009"]}, {"Citation": "Gupta S., Ellis S. E., Ashar F. N., Moes A., Bader J. S., Zhan J., et al. (2014). Transcriptome analysis reveals dysregulation of innate immune response genes and neuronal activity-dependent genes in autism. Nat. Commun. 5:5748. 10.1038/ncomms6748", "ArticleIdList": ["10.1038/ncomms6748", "PMC4270294", "25494366"]}, {"Citation": "Herrero M. J., Velmeshev D., Hernandez-Pineda D., Sethi S., Sorrells S., Banerjee P., et al. (2020). Identification of amygdala-expressed genes associated with autism spectrum disorder. Mol. Autism 11:39. 10.1186/s13229-020-00346-1", "ArticleIdList": ["10.1186/s13229-020-00346-1", "PMC7251751", "32460837"]}, {"Citation": "Inestrosa N. C., Varela-Nallar L. (2015). Wnt signalling in neuronal differentiation and development. Cell Tissue Res. 359 215\u2013223. 10.1007/s00441-014-1996-4", "ArticleIdList": ["10.1007/s00441-014-1996-4", "25234280"]}, {"Citation": "Ishii A., Furusho M., Bansal R. (2021). Mek/ERK1/2-MAPK and PI3K/Akt/mTOR signaling plays both independent and cooperative roles in Schwann cell differentiation, myelination and dysmyelination. Glia 69 2429\u20132446. 10.1002/glia.24049", "ArticleIdList": ["10.1002/glia.24049", "PMC8373720", "34157170"]}, {"Citation": "Ishii A., Furusho M., Dupree J. L., Bansal R. (2016). Strength of ERK1/2 MAPK activation determines its effect on myelin and axonal integrity in the adult CNS. J. Neurosci. 36 6471\u20136487. 10.1523/JNEUROSCI.0299-16.2016", "ArticleIdList": ["10.1523/JNEUROSCI.0299-16.2016", "PMC5015783", "27307235"]}, {"Citation": "Ishii A., Furusho M., Macklin W., Bansal R. (2019). Independent and cooperative roles of the Mek/ERK1/2-MAPK and PI3K/Akt/mTOR pathways during developmental myelination and in adulthood. Glia 67 1277\u20131295. 10.1002/glia.23602", "ArticleIdList": ["10.1002/glia.23602", "PMC6571146", "30761608"]}, {"Citation": "Kataoka S., Takuma K., Hara Y., Maeda Y., Ago Y., Matsuda T. (2013). Autism-like behaviours with transient histone hyperacetylation in mice treated prenatally with valproic acid. Int. J. Neuropsychopharmacol. 16 91\u2013103. 10.1017/S1461145711001714", "ArticleIdList": ["10.1017/S1461145711001714", "22093185"]}, {"Citation": "Kim D., Paggi J. M., Park C., Bennett C., Salzberg S. L. (2019). Graph-based genome alignment and genotyping with HISAT2 and HISAT-genotype. Nat. Biotechnol. 37 907\u2013915. 10.1038/s41587-019-0201-4", "ArticleIdList": ["10.1038/s41587-019-0201-4", "PMC7605509", "31375807"]}, {"Citation": "Kim H. K., Lee D. W., Kim E., Jeong I., Kim S., Kim B. J., et al. (2020). Notch signaling controls oligodendrocyte regeneration in the injured telencephalon of adult zebrafish. Exp. Neurobiol. 29 417\u2013424. 10.5607/en20050", "ArticleIdList": ["10.5607/en20050", "PMC7788307", "33281119"]}, {"Citation": "Kumar L., Futschik M. E. (2007). Mfuzz: a software package for soft clustering of microarray data. Bioinformation 2 5\u20137. 10.6026/97320630002005", "ArticleIdList": ["10.6026/97320630002005", "PMC2139991", "18084642"]}, {"Citation": "Kumar S., Reynolds K., Ji Y., Gu R., Rai S., Zhou C. J. (2019). Impaired neurodevelopmental pathways in autism spectrum disorder: a review of signaling mechanisms and crosstalk. J. Neurodev. Disord. 11:10. 10.1186/s11689-019-9268-y", "ArticleIdList": ["10.1186/s11689-019-9268-y", "PMC6571119", "31202261"]}, {"Citation": "Kuo H. Y., Liu F. C. (2018). Molecular pathology and pharmacological treatment of autism spectrum disorder-like phenotypes using rodent models. Front. Cell Neurosci. 12:422. 10.3389/fncel.2018.00422", "ArticleIdList": ["10.3389/fncel.2018.00422", "PMC6262306", "30524240"]}, {"Citation": "Lafrenaye A. D., Fuss B. (2010). Focal adhesion kinase can play unique and opposing roles in regulating the morphology of differentiating oligodendrocytes. J. Neurochem. 115 269\u2013282. 10.1111/j.1471-4159.2010.06926.x", "ArticleIdList": ["10.1111/j.1471-4159.2010.06926.x", "PMC2939935", "20649846"]}, {"Citation": "Li C., Xie Z., Xing Z., Zhu H., Zhou W., Xie S., et al. (2021). The notch signaling pathway regulates differentiation of ng2 cells into oligodendrocytes in demyelinating diseases. Cell Mol. Neurobiol. 10.1007/s10571-021-01089-0 [Epub ahead of print].", "ArticleIdList": ["10.1007/s10571-021-01089-0", "33826017"]}, {"Citation": "Liberzon A., Birger C., Thorvaldsdottir H., Ghandi M., Mesirov J. P., Tamayo P. (2015). The molecular signatures database (MSigDB) hallmark gene set collection. Cell Syst. 1 417\u2013425. 10.1016/j.cels.2015.12.004", "ArticleIdList": ["10.1016/j.cels.2015.12.004", "PMC4707969", "26771021"]}, {"Citation": "Liberzon A., Subramanian A., Pinchback R., Thorvaldsdottir H., Tamayo P., Mesirov J. P. (2011). Molecular signatures database (MSigDB) 3.0. Bioinformatics 27 1739\u20131740. 10.1093/bioinformatics/btr260", "ArticleIdList": ["10.1093/bioinformatics/btr260", "PMC3106198", "21546393"]}, {"Citation": "Livak K. J., Schmittgen T. D. (2001). Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 25 402\u2013408. 10.1006/meth.2001.1262", "ArticleIdList": ["10.1006/meth.2001.1262", "11846609"]}, {"Citation": "Lord C., Brugha T. S., Charman T., Cusack J., Dumas G., Frazier T., et al. (2020). Autism spectrum disorder. Nat. Rev. Dis. Primers 6:5.", "ArticleIdList": ["PMC8900942", "31949163"]}, {"Citation": "Lorenzati M., Boda E., Parolisi R., Bonato M., Borsello T., Herdegen T., et al. (2021). c-Jun N-terminal kinase 1 (JNK1) modulates oligodendrocyte progenitor cell architecture, proliferation and myelination. Sci. Rep. 11:7264. 10.1038/s41598-021-86673-6", "ArticleIdList": ["10.1038/s41598-021-86673-6", "PMC8012703", "33790350"]}, {"Citation": "Love M. I., Huber W., Anders S. (2014). Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2. Genome Biol. 15:550. 10.1186/s13059-014-0550-8", "ArticleIdList": ["10.1186/s13059-014-0550-8", "PMC4302049", "25516281"]}, {"Citation": "Luo T., Ou J. N., Cao L. F., Peng X. Q., Li Y. M., Tian Y. Q. (2020). The autism-related lncRNA MSNP1AS regulates moesin protein to influence the RhoA, Rac1, and PI3K/Akt pathways and regulate the structure and survival of neurons. Autism Res. 13 2073\u20132082. 10.1002/aur.2413", "ArticleIdList": ["10.1002/aur.2413", "33215882"]}, {"Citation": "Mahmood H. M., Aldhalaan H. M., Alshammari T. K., Alqasem M. A., Alshammari M. A., Albekairi N. A., et al. (2020). The role of nicotinic receptors in the attenuation of autism-related behaviors in a murine BTBR T + tf/J Autistic model. Autism Res. 13 1311\u20131334. 10.1002/aur.2342", "ArticleIdList": ["10.1002/aur.2342", "32691528"]}, {"Citation": "Mootha V. K., Lindgren C. M., Eriksson K. F., Subramanian A., Sihag S., Lehar J., et al. (2003). PGC-1alpha-responsive genes involved in oxidative phosphorylation are coordinately downregulated in human diabetes. Nat. Genet. 34 267\u2013273. 10.1038/ng1180", "ArticleIdList": ["10.1038/ng1180", "12808457"]}, {"Citation": "Nicolini C., Ahn Y., Michalski B., Rho J. M., Fahnestock M. (2015). Decreased mTOR signaling pathway in human idiopathic autism and in rats exposed to valproic acid. Acta Neuropathol. Commun. 3:3. 10.1186/s40478-015-0184-4", "ArticleIdList": ["10.1186/s40478-015-0184-4", "PMC4307681", "25627160"]}, {"Citation": "Oztan O., Garner J. P., Constantino J. N., Parker K. J. (2020). Neonatal CSF vasopressin concentration predicts later medical record diagnoses of autism spectrum disorder. Proc. Natl. Acad. Sci. U.S.A. 117 10609\u201310613. 10.1073/pnas.1919050117", "ArticleIdList": ["10.1073/pnas.1919050117", "PMC7229671", "32341146"]}, {"Citation": "Oztan O., Garner J. P., Partap S., Sherr E. H., Hardan A. Y., Farmer C., et al. (2018). Cerebrospinal fluid vasopressin and symptom severity in children with autism. Ann. Neurol. 84 611\u2013615. 10.1002/ana.25314", "ArticleIdList": ["10.1002/ana.25314", "PMC6719782", "30152888"]}, {"Citation": "Parker K. J., Garner J. P., Oztan O., Tarara E. R., Li J., Sclafani V., et al. (2018). Arginine vasopressin in cerebrospinal fluid is a marker of sociality in nonhuman primates. Sci. Transl. Med. 10:eaam9100. 10.1126/scitranslmed.aam9100", "ArticleIdList": ["10.1126/scitranslmed.aam9100", "PMC6714978", "29720452"]}, {"Citation": "Parker K. J., Oztan O., Libove R. A., Mohsin N., Karhson D. S., Sumiyoshi R. D., et al. (2019). A randomized placebo-controlled pilot trial shows that intranasal vasopressin improves social deficits in children with autism. Sci. Transl. Med. 11:eaau7356. 10.1126/scitranslmed.aau7356", "ArticleIdList": ["10.1126/scitranslmed.aau7356", "PMC6716148", "31043522"]}, {"Citation": "Phan B. N., Bohlen J. F., Davis B. A., Ye Z., Chen H. Y., Mayfield B., et al. (2020). A myelin-related transcriptomic profile is shared by Pitt-Hopkins syndrome models and human autism spectrum disorder. Nat. Neurosci. 23 375\u2013385. 10.1038/s41593-019-0578-x", "ArticleIdList": ["10.1038/s41593-019-0578-x", "PMC7065955", "32015540"]}, {"Citation": "Qin L., Dai X., Yin Y. (2016). Valproic acid exposure sequentially activates Wnt and mTOR pathways in rats. Mol. Cell Neurosci. 75 27\u201335. 10.1016/j.mcn.2016.06.004", "ArticleIdList": ["10.1016/j.mcn.2016.06.004", "27343825"]}, {"Citation": "Raam T., Hong W. (2021). Organization of neural circuits underlying social behavior: a consideration of the medial amygdala. Curr. Opin. Neurobiol. 68 124\u2013136. 10.1016/j.conb.2021.02.008", "ArticleIdList": ["10.1016/j.conb.2021.02.008", "PMC8243811", "33940499"]}, {"Citation": "Raudvere U., Kolberg L., Kuzmin I., Arak T., Adler P., Peterson H., et al. (2019). G:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update). Nucleic Acids Res. 47 W191\u2013W198. 10.1093/nar/gkz369", "ArticleIdList": ["10.1093/nar/gkz369", "PMC6602461", "31066453"]}, {"Citation": "Rein B., Ma K., Yan Z. (2020). A standardized social preference protocol for measuring social deficits in mouse models of autism. Nat. Protoc. 15 3464\u20133477. 10.1038/s41596-020-0382-9", "ArticleIdList": ["10.1038/s41596-020-0382-9", "PMC8103520", "32895524"]}, {"Citation": "Schneider T., Przewlocki R. (2005). Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Neuropsychopharmacology 30 80\u201389. 10.1038/sj.npp.1300518", "ArticleIdList": ["10.1038/sj.npp.1300518", "15238991"]}, {"Citation": "Seguin D., Pac S., Wang J., Nicolson R., Martinez-Trujillo J., Duerden E. G. (2021). Amygdala subnuclei development in adolescents with autism spectrum disorder: association with social communication and repetitive behaviors. Brain Behav. 11:e2299. 10.1002/brb3.2299", "ArticleIdList": ["10.1002/brb3.2299", "PMC8413788", "34333868"]}, {"Citation": "Servadio M., Manduca A., Melancia F., Leboffe L., Schiavi S., Campolongo P., et al. (2018). Impaired repair of DNA damage is associated with autistic-like traits in rats prenatally exposed to valproic acid. Eur. Neuropsychopharmacol. 28 85\u201396. 10.1016/j.euroneuro.2017.11.014", "ArticleIdList": ["10.1016/j.euroneuro.2017.11.014", "29174949"]}, {"Citation": "Sharma A., Mehan S. (2021). Targeting PI3K-AKT/mTOR signaling in the prevention of autism. Neurochem. Int. 147:105067. 10.1016/j.neuint.2021.105067", "ArticleIdList": ["10.1016/j.neuint.2021.105067", "33992742"]}, {"Citation": "Shen M. D., Li D. D., Keown C. L., Lee A., Johnson R. T., Angkustsiri K., et al. (2016). Functional connectivity of the amygdala is disrupted in preschool-aged children with autism spectrum disorder. J. Am. Acad. Child Adolesc. Psychiatry 55 817\u2013824. 10.1016/j.jaac.2016.05.020", "ArticleIdList": ["10.1016/j.jaac.2016.05.020", "PMC5003422", "27566123"]}, {"Citation": "Sparapani S., Millet-Boureima C., Oliver J., Mu K., Hadavi P., Kalostian T., et al. (2021). The biology of vasopressin. Biomedicines 9:89.", "ArticleIdList": ["PMC7832310", "33477721"]}, {"Citation": "Subramanian A., Tamayo P., Mootha V. K., Mukherjee S., Ebert B. L., Gillette M. A., et al. (2005). Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U.S.A. 102 15545\u201315550. 10.1073/pnas.0506580102", "ArticleIdList": ["10.1073/pnas.0506580102", "PMC1239896", "16199517"]}, {"Citation": "Taleb A., Lin W., Xu X., Zhang G., Zhou Q. G., Naveed M., et al. (2021). Emerging mechanisms of valproic acid-induced neurotoxic events in autism and its implications for pharmacological treatment. Biomed. Pharmacother. 137:111322. 10.1016/j.biopha.2021.111322", "ArticleIdList": ["10.1016/j.biopha.2021.111322", "33761592"]}, {"Citation": "Tylee D. S., Hess J. L., Quinn T. P., Barve R., Huang H., Zhang-James Y., et al. (2017). Blood transcriptomic comparison of individuals with and without autism spectrum disorder: a combined-samples mega-analysis. Am. J. Med. Genet. B Neuropsychiatr. Genet. 174 181\u2013201. 10.1002/ajmg.b.32511", "ArticleIdList": ["10.1002/ajmg.b.32511", "PMC5499528", "27862943"]}, {"Citation": "Vallee A., Vallee J. N., Lecarpentier Y. (2019). PPARgamma agonists: potential treatment for autism spectrum disorder by inhibiting the canonical WNT/beta-catenin pathway. Mol. Psychiatry 24 643\u2013652. 10.1038/s41380-018-0131-4", "ArticleIdList": ["10.1038/s41380-018-0131-4", "30104725"]}, {"Citation": "Vitor-Vieira F., Vilela F. C., Giusti-Paiva A. (2021). Hyperactivation of the amygdala correlates with impaired social play behavior of prepubertal male rats in a maternal immune activation model. Behav. Brain Res. 414:113503. 10.1016/j.bbr.2021.113503", "ArticleIdList": ["10.1016/j.bbr.2021.113503", "34331970"]}, {"Citation": "Voineagu I., Wang X., Johnston P., Lowe J. K., Tian Y., Horvath S., et al. (2011). Transcriptomic analysis of autistic brain reveals convergent molecular pathology. Nature 474 380\u2013384. 10.1038/nature10110", "ArticleIdList": ["10.1038/nature10110", "PMC3607626", "21614001"]}, {"Citation": "Worthmuller J., Ruegg C. (2020). The crosstalk between FAK and Wnt signaling pathways in cancer and its therapeutic implication. Int. J. Mol. Sci. 21:9107. 10.3390/ijms21239107", "ArticleIdList": ["10.3390/ijms21239107", "PMC7730291", "33266025"]}, {"Citation": "Wu J., Dai Y. C., Lan X. Y., Zhang H. F., Bai S. Z., Hu Y., et al. (2021). Postnatal AVP treatments prevent social deficit in adolescence of valproic acid-induced rat autism model. Peptides 137:170493. 10.1016/j.peptides.2021.170493", "ArticleIdList": ["10.1016/j.peptides.2021.170493", "33422647"]}, {"Citation": "Xu Q., Zuo C., Liao S., Long Y., Wang Y. (2020). Abnormal development pattern of the amygdala and hippocampus from childhood to adulthood with autism. J. Clin. Neurosci. 78 327\u2013332. 10.1016/j.jocn.2020.03.049", "ArticleIdList": ["10.1016/j.jocn.2020.03.049", "32593622"]}, {"Citation": "Xu S., Jiang M., Liu X., Sun Y., Yang L., Yang Q., et al. (2021). Neural circuits for social interactions: from microcircuits to input-output circuits. Front. Neural Circuits 15:768294. 10.3389/fncir.2021.768294", "ArticleIdList": ["10.3389/fncir.2021.768294", "PMC8585935", "34776877"]}, {"Citation": "Yu G., Wang L. G., Han Y., He Q. Y. (2012). clusterProfiler: an R package for comparing biological themes among gene clusters. OMICS 16 284\u2013287. 10.1089/omi.2011.0118", "ArticleIdList": ["10.1089/omi.2011.0118", "PMC3339379", "22455463"]}, {"Citation": "Zalla T., Sperduti M. (2013). The amygdala and the relevance detection theory of autism: an evolutionary perspective. Front. Hum. Neurosci. 7:894. 10.3389/fnhum.2013.00894", "ArticleIdList": ["10.3389/fnhum.2013.00894", "PMC3874476", "24416006"]}, {"Citation": "Zhang H. F., Dai Y. C., Wu J., Jia M. X., Zhang J. S., Shou X. J., et al. (2016). Plasma oxytocin and arginine-vasopressin levels in children with autism spectrum disorder in china: associations with symptoms. Neurosci. Bull. 32 423\u2013432. 10.1007/s12264-016-0046-5", "ArticleIdList": ["10.1007/s12264-016-0046-5", "PMC5563759", "27342432"]}, {"Citation": "Zhang J., Zhang J. X., Zhang Q. L. (2016). PI3K/AKT/mTOR-mediated autophagy in the development of autism spectrum disorder. Brain Res. Bull. 125 152\u2013158. 10.1016/j.brainresbull.2016.06.007", "ArticleIdList": ["10.1016/j.brainresbull.2016.06.007", "27320472"]}, {"Citation": "Zhang W., Ma L., Yang M., Shao Q., Xu J., Lu Z., et al. (2020). Cerebral organoid and mouse models reveal a RAB39b-PI3K-mTOR pathway-dependent dysregulation of cortical development leading to macrocephaly/autism phenotypes. Genes Dev. 34 580\u2013597. 10.1101/gad.332494.119", "ArticleIdList": ["10.1101/gad.332494.119", "PMC7111266", "32115408"]}, {"Citation": "Zhang X. F., Chen T., Yan A., Xiao J., Xie Y. L., Yuan J., et al. (2020). Poly(I:C) challenge alters brain expression of oligodendroglia-related genes of adult progeny in a mouse model of maternal immune activation. Front. Mol. Neurosci. 13:115. 10.3389/fnmol.2020.00115", "ArticleIdList": ["10.3389/fnmol.2020.00115", "PMC7340146", "32714147"]}, {"Citation": "Zhang Y., Sun Y., Wang F., Wang Z., Peng Y., Li R. (2012). Downregulating the canonical Wnt/beta-catenin signaling pathway attenuates the susceptibility to autism-like phenotypes by decreasing oxidative stress. Neurochem. Res. 37 1409\u20131419. 10.1007/s11064-012-0724-2", "ArticleIdList": ["10.1007/s11064-012-0724-2", "22374471"]}, {"Citation": "Zhang Y., Yang C., Yuan G., Wang Z., Cui W., Li R. (2015). Sulindac attenuates valproic acid-induced oxidative stress levels in primary cultured cortical neurons and ameliorates repetitive/stereotypic-like movement disorders in Wistar rats prenatally exposed to valproic acid. Int. J. Mol. Med. 35 263\u2013270. 10.3892/ijmm.2014.1996", "ArticleIdList": ["10.3892/ijmm.2014.1996", "25384498"]}, {"Citation": "Zhou H., Xu X., Yan W., Zou X., Wu L., Luo X., et al. (2020). Prevalence of autism spectrum disorder in china: a nationwide multi-center population-based study among children aged 6 to 12 Years. Neurosci. Bull. 36 961\u2013971. 10.1007/s12264-020-00530-6", "ArticleIdList": ["10.1007/s12264-020-00530-6", "PMC7475160", "32607739"]}], "ReferenceList": []}], "History": [{"Year": "2021", "Month": "12", "Day": "18"}, {"Year": "2022", "Month": "1", "Day": "31"}, {"Year": "2022", "Month": "4", "Day": "11", "Hour": "5", "Minute": "27"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "4", "Day": "12", "Hour": "6", "Minute": "1"}, {"Year": "2022", "Month": "1", "Day": "1"}], "PublicationStatus": "epublish", "ArticleIdList": ["35401102", "PMC8990166", "10.3389/fnins.2022.838942"]}}], "PubmedBookArticle": []}